Status:
COMPLETED
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)
Lead Sponsor:
Armando Santoro, MD
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the study is to evaluated the role of IGF1R and p95HER2 on prognosis in radically resected non small cell lung cancer patients The primary objective is to correlate the expression of IGF1R and...
Eligibility Criteria
Inclusion
- Radically resected non small cell lung cancer patients with tumor tissue available
Exclusion
- Tumor tissue not available
- Clinical data not available
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT00763607
Start Date
November 1 2007
End Date
December 1 2009
Last Update
September 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinco Humanitas
Rozzano, Milan, Italy, 20089